In Vitro Release Studies Would Serve As DPK Adjunct Under FDA Proposal
This article was originally published in The Rose Sheet
Executive Summary
In vitro drug release studies would be required as an adjunct to dermatopharmacokinetics (skin stripping) for establishing the bioequivalence of topical drug products under proposed changes to an FDA draft guidance.